你即將離開本站

並前往https://www.nytimes.com/2021/11/17/business/biogens-alzheimers-aduhelm-european-union.html

Biogen's Alzheimer's drug is unlikely to win EU approval.

Biogen said it would continue to work with European Union regulators “as it considers next steps” to try to get the drug approved in Europe.

確定！ 回上一頁

查詢 「Biogen」的人也找了：

  1. biogen藥物
    2.
  2. biogen作用
    3.
  3. biogen台灣
    4.
  4. biogen美股
    5.
  5. biogen藥廠
    6.
  6. biogen公司
    7.
  7. Biogen
    8.
  8. biogen財報
    9.